Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | Sublingual tizanidine 12 mg | 1件: Tizanidine Tizanidine | 2件: D00776
D00776
(Name: Tizanidine hydrochloride),D08611 (Name: Tizanidine) | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |
| 2 | Tizanidine | 1件: Tizanidine Tizanidine | 2件: D00776
D00776
(Name: Tizanidine hydrochloride),D08611 (Name: Tizanidine) | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |
| 3 | Tizanidine (sublingual or oral) | 1件: Tizanidine Tizanidine | 2件: D00776
D00776
(Name: Tizanidine hydrochloride),D08611 (Name: Tizanidine) | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |
| 4 | Tizanidine hydrochloride capsule | 1件: Tizanidine Tizanidine | 2件: D00776
D00776
(Name: Tizanidine hydrochloride),D08611 (Name: Tizanidine) | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |